NEW YORK--(BUSINESS WIRE)--Cronus Partners LLC (Cronus) is pleased to announce it acted as the financial advisor to Bio-Botanica® Inc. (Bio-Botanica) in a working capital, construction, and equipment financing through credit facilities provided by Wells Fargo Bank, N.A. Bio-Botanica is a leading manufacturer of over 500 quality botanical extracts for the cosmetic, personal care, pharmaceutical and nutraceutical industries.
“Cronus’ support on both financings and acquisitions is key to our continued growth and success as a major competitor in the botanicals industry,” commented Frank D’Amelio, Jr., Executive Vice President of Bio-Botanica.
Jeffrey Rubin, Managing Director of Cronus, added, “Understanding our clients’ businesses and where they fit within their industry enables us to add value beyond the typical investment banking role.”
About Bio-Botanica
Headquartered in Hauppauge, New York, Bio-Botanica (www.bio-botanica.com) is a family-owned and operated company, specializing in botanicals for over 40 years. A well-recognized industry innovator known for pioneering numerous advancements in the botanical field, the company owns and operates North America’s most extensive pharmaceutically licensed herbal manufacturing and quality control facilities and is cGMP compliant, Kosher and Organic certified and NSF Registered, assuring the highest quality.
About Cronus Partners
Advising on mergers, acquisitions, divestitures, sales, and private placement financings, Cronus Partners is an independent investment banking firm that provides financial advisory and other investment banking services. Winner of the New York Association for Corporate Growth’s Boutique Investment Bank of the Year Award, the firm has significant experience in advising both public and private companies that can benefit from middle-market transactions. To learn more, please visit www.CronusPartners.com.
